Factors influencing overweight childrens commencement of and continuation in a resistance training program

Pescud, Melanie; Pettigrew, Simone; McGuigan, Michael R.; Newton, Robert U.
January 2010
BMC Public Health;2010, Vol. 10, p709
Academic Journal
Background: In light of the child overweight and obesity problem in Australia, resistance training programs have been trialled as an innovative way of assisting children increase lean body mass and reduce body fat. The purpose of this study was to investigate the factors influencing overweight children's participation in a resistance training trial program. Method: Parent-child pairs who participated in the trial program were invited to take part in a follow-up individual interview to discuss their program experiences. In total, 22 semi-structured interviews were conducted with 11 parent-child pairs. Results: The factors found to be most relevant to program commencement among parents were a desire for their child to lose weight and gain confidence, the proximity of the venue, and no cost for participation. For children, the most relevant factors were the opportunity to build strength and improve fitness and having supportive parents who facilitated program initiation. The factors most relevant to continuation for parents were the quality of the program management, being able to stay for the sessions, the child's improved weight status, coordination, and confidence, and no cost for participation. Weight loss and improved confidence were also motivators for continuation among the children, along with pleasant social interaction with peers and trainers and ongoing parental support. Conclusion: Different factors variably influence program commencement and program continuation in both parents and children. This has important implications for future interventions that aim to successfully recruit and retain intervention participants.


Related Articles

  • Rimonabant: a guide to its use in obese and overweight patients.  // Drugs & Therapy Perspectives;Aug2007, Vol. 23 Issue 8, p5 

    The article offers clinical information on rimonabant. Rimonabant was developed for use in obese and overweight patients. It acts by selectively inhibiting the action of central and peripheral cannabinoid agonists and the proliferation and maturation of fat cells. It is indicated for obese or...

  • The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient? Douketis, James D.; Sharma, Arya M. // Drugs;2004, Vol. 64 Issue 8, p795 

    The management of hypertension in the overweight and obese patient is a frequently encountered but under investigated clinical problem. The conventional management of such patients involves weight reduction with dietary therapy or a combined approach with dietary and anti-obesity drug therapy....

  • Análisis de un programa de pérdida de peso con sustitutivos de comidas sobre el control del peso y de parámetros bioquímicos en pacientes con sobrepeso y obesidad grado I. Basulto, J.; Bultó, L.; Chamorro, M.; Lafuente, C.; Martín, E.; Porta, G. // Nutricion Hospitalaria;jul/aug2008, Vol. 23 Issue 4, p388 

    Background: There are scarce data about the efficacy and security of meal replacement products as a strategy to weight loss. Aim: To evaluate the efficacy and safety of a weight loss program that includes meal replacement products. Methods: We evaluated the effect of a hypocaloric diet versus a...

  • Orlistat, sibutramine, and rimonabant reduce weight in overweight and obese persons. Kanaya, Alka M. // ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p24 

    The article focuses on 30 randomized controlled trials (RCTs) investigating the long-term efficacy of antiobesity drugs (AODs) for reducing weight and improving health status in overweight or obese persons. Trials found out that orlistat, sibutramine and rimonabant reduces weight and improve...

  • OTC Product: Alli. Marshall, Leisa L. // Journal of the American Pharmacists Association: JAPhA;Jul/Aug2007, Vol. 47 Issue 4, p544 

    The article offers information on Alli, an over-the-counter agent launched by GlaxoSmithKline in the U.S. used for obesity management. It notes that each capsule contains 60 milligrams of orlistat and used for overweight and obese adults. It states that the drug was the first weight loss product...

  • Circadian rhythmicity as a predictor of weight-loss effectiveness. Bandín, C; Martinez-Nicolas, A; Ordovás, J M; Madrid, J A; Garaulet, M // International Journal of Obesity;Aug2014, Vol. 38 Issue 8, p1083 

    Objectives:Some of the major challenges associated with successful dietary weight management include the identification of individuals not responsive to specific interventions. The aim was to investigate the potential relationship between weight loss and circadian rhythmicity, using wrist...

  • Crushing Corpulence with Customized Solutions. Schofield, Lisa // Nutraceuticals World;Sep2014, Vol. 17 Issue 7, p32 

    The article looks at the specific weight management formula to address the needs of people affected by different factors that cause obesity. It highlights the large number of adults in the U.S. who are obese, despite of awareness about the benefits of nutrition, healthy eating habits, and...

  • A diet is for life, not just for New Year. Cloake, Felicity // New Statesman;1/9/2012, Vol. 141 Issue 5087, p57 

    The author offers opinions on weight loss diets, dieting and nutrition. The book "Calories & Corsets," by Louise Foxcroft on the history of weight loss is cited in support of the contentions that overweight persons have been subject to social disapproval for centuries and that there has always...

  • A study of university students and pharmacists' perspectives on weight management. Luevorasirikul, K.; Boardman, H. F.; Anderson, C. W. // International Journal of Health Promotion & Education;2010, Vol. 48 Issue 2, p42 

    Objective: The aim of this study was to investigate university students and pharmacists attitudes towards weight control products. Method: Semi-structured interviews with twenty university students and eight community pharmacists in the East Midlands of the United Kingdom. Results: Young adults...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics